Article
A polymorphism at the 3'-UTR region of the aromatase gene is associated with the efficacy of the aromatase inhibitor, anastrozole, in metastatic breast carcinoma.
International journal of molecular sciences - 13 Sept 2013
Liu Lei, Bai Yu-Xian, Zhou Jian-Hua, Sun Xiu-Wei, Sui Hong, Zhang Wen-Jie, Yuan Heng-Heng, Xie Rui, Wei Xiao-Li, Zhang Ting-Ting, Huang Peng, Li Yan-Jing, Wang Jing-Xuan, Zhao Shu, Zhang Qing-Yuan
Abstract excerpt
Estrogen-related genes and the fat mass and obesity-associated (FTO) gene play a critical role in estrogen metabolism, and those polymorphisms are associated with a poor prognosis in breast cancer. However, little is known about the association between these polymorphisms and the efficacy of anastrozole. The aim was to investigate the impact of the genetic polymorphisms, CYP19A1, 17-β-HSD-1 and FTO, on the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
